C-reactive Protein Concentration Is Associated With a Higher Risk of Mortality in a Rural Korean Population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: C-reactive protein (CRP), an inflammatory biomarker, has been widely used as a preclinical marker predictive of morbidity and mortality. Although many studies have reported a positive association between CRP and mortality, uncertainty still remains about this association in various populations, especially in rural Korea. Methods: A total of 23 233 middle-aged participants (8862 men and 14 371 women) who were free from cardiovascular disease, cancer, and acute inflammation (defined by a CRP level ≥10 mg/L) were drawn from 11 rural communities in Korea between 2005 and 2011. Blood CRP concentration was analyzed as a categorical variable (low: 0.0-0.9 mg/L; intermediate: 1.0-3.0 mg/L; high: 3.1-9.9 mg/L) as well as a continuous variable. Each participant’s vital status through December 2013 was confirmed by death statistics from the National Statistical Office. Cox proportional hazard models were used to assess the independent association between CRP and mortality after adjusting for other risk factors. Results: The total quantity of observed person-years was 57 975 for men and 95 146 for women, and the number of deaths was 649 among men and 367 among women. Compared to the low-CRP group, the adjusted hazard ratio for all-cause mortality of the intermediate group was 1.17 (95% confidence interval [CI], 0.98 to 1.40) for men and 1.27 (95% CI, 1.01 to 1.61) for women, and the corresponding values for the high-CRP group were 1.98 (95% CI, 1.61 to 2.42) for men and 1.41 (95% CI, 1.03 to 1.95) for women. Similar trends were found for CRP evaluated as a continuous variable and for cardiovascular mortality. Conclusions: Higher CRP concentrations were associated with higher mortality in a rural Korean population, and this association was more prominent in men than in women.
Abstract
Objectives: C-reactive protein (CRP), an inflammatory biomarker, has been widely used as a preclinical marker predictive of morbidity and mortality. Although many studies have reported a positive association between CRP and mortality, uncertainty still remains about this association in various populations, especially in rural Korea. Methods: A total of 23 233 middle-aged participants (8862 men and 14 371 women) who were free from cardiovascular disease, cancer, and acute inflammation (defined by a CRP level ≥10 mg/L) were drawn from 11 rural communities in Korea between 2005 and 2011. Blood CRP concentration was analyzed as a categorical variable (low: 0.0-0.9 mg/L; intermediate: 1.0-3.0 mg/L; high: 3.1-9.9 mg/L) as well as a continuous variable. Each participant’s vital status through December 2013 was confirmed by death statistics from the National Statistical Office. Cox proportional hazard models were used to assess the independent association between CRP and mortality after adjusting for other risk factors. Results: The total quantity of observed person-years was 57 975 for men and 95 146 for women, and the number of deaths was 649 among men and 367 among women. Compared to the low-CRP group, the adjusted hazard ratio for all-cause mortality of the intermediate group was 1.17 (95% confidence interval [CI], 0.98 to 1.40) for men and 1.27 (95% CI, 1.01 to 1.61) for women, and the corresponding values for the high-CRP group were 1.98 (95% CI, 1.61 to 2.42) for men and 1.41 (95% CI, 1.03 to 1.95) for women. Similar trends were found for CRP evaluated as a continuous variable and for cardiovascular mortality. Conclusions: Higher CRP concentrations were associated with higher mortality in a rural Korean population, and this association was more prominent in men than in women.
참고문헌 (37)
- Libby P, "Inflammatory mechanisms: the molecular basis of inflammation and disease", Nutr Rev, 65(Su TC), pp.S140~S146 (2007)
- Shacter E, "Chronic inflammation and cancer", Oncology (Williston Park), 16(2), pp.217~226 (2002)
- Willerson JT, "Inflammation as a cardiovascular risk factor", Circulation, 109(21 Suppl 1), pp.II2~II10 (2004)
- Windgassen EB, "C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians", Postgrad Med, 123(1), pp.114~119 (2011)
- NACB LMPG Committee Members, "National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease", Clin Chem, 55(2), pp.378~384 (2009)
- Makita S, "Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population", Atherosclerosis, 204(1), pp.234~238 (2009)
- Emerging Risk Factors Collaboration, "C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis", Lancet, 375(9709), pp.132~140 (2010)
- Ridker PM, "High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care", Clin Chem, 54(2), pp.234~237 (2008)
- Ahmadi-Abhari S, "Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study", Eur J Epidemiol, 28(7), pp.541~550 (2013)
- Goyal A, "C-reactive protein and colorectal cancer mortality in U.S. adults", Cancer Epidemiol Biomarkers Prev, 23(8), pp.1609~1618 (2014)
- Sung KC, "C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians", Eur Heart J, 35(27), pp.1809~1816 (2014)
- Doran B, "Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III", Am Heart J, 166(1), pp.45~51 (2013)
- Kim KI, "CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population", Am J Med, 125(8), pp.787~795 (2012)
- Ding D, "Body mass index, high-sensitivity C-reactive protein and mortality in Chinese with coronary artery disease", PLoS One, 10(8), pp.e0135713~ (2015)
- Sung JW, "High-sensitivity C-reactive protein is associated with the presence of coronary artery calcium in subjects with normal blood pressure but not in subjects with hypertension", Arch Med Res, 45(2), pp.170~176 (2014)
- Kengne AP, "Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies", Diabetes Care, 35(2), pp.396~403 (2012)
- Koenig W, "Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA", KORA Augsburg Cohort Study, 1984-1998, 2008, pp.54(2), 335~342
- Yusuf S, "Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies", Circulation, 104(23), pp.2855~2864 (2001)
- Miranda JJ, "Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru", Heart, 97(10), pp.787~796 (2011)
- Kelley-Hedgepeth A, "Ethnic differences in C-reactive protein concentrations", Clin Chem, 54(6), pp.1027~1037 (2008)
- Kim Y, "Cohort profile: the Korean genome and epidemiology study (KoGES) Consortium", Int J Epidemiol (2016)
- 이은하, "한국인의 흡연과 사망 위험에 관한 코호트 연구", 예방의학회지, 43(2), pp.151~158 (2010), 대한예방의학회
- "The Asia-Pacific perspective: rede-fining obesity and its treatment"[URL]
- Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18(6), pp.499~502 (1972)
- Heinzl H, "Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions", Comput Methods Programs Biomed, 54(3), pp.201~208 (1997)
- "The SAS LGTPHCURV9 macro" (2011)[URL]
- Iso H, "C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study", Atherosclerosis, 207(1), pp.291~297 (2009)
- Currie CJ, "Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality", Heart, 94(4), pp.457~462 (2008)
- Pearson TA, "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107(3), pp.499~511 (2003)
- Woloshin S, "Distribution of C-reactive protein values in the United States", N Engl J Med, 352(15), pp.1611~1613 (2005)
- Saito I, "A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study", Atherosclerosis, 194(1), pp.238~244 (2007)
- Zhao Y, "Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese", Dis Markers, 28(6), pp.333~342 (2010)
- "Health status"[URL]
- Kuoppamäki M, "High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year follow-up study", Arch Gerontol Geriatr, 60(1), pp.112~117 (2015)
- Smith KB, "Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research", Aust J Rural Health, 16(2), pp.56~66 (2008)
- Hage FG, "C-reactive protein and hypertension", J Hum Hypertens, 28(7), pp.410~415 (2014)
- Ridker PM, "Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial", Lancet, 373(9670), pp.1175~1182 (2009)